Global Bioresorbable Surgical Material Market Key Players and Market Share 2026-2033

The global bioresorbable surgical material market is set for clear expansion between 2026 and 2033, with revenue projected to rise from about $4.1 billion in 2026 to nearly $7.2 billion by 2033, reflecting a CAGR of 8.2%. Demand is being shaped by the shift toward absorbable fixation, tissue repair, wound closure, and reconstructive procedures that reduce the need for removal surgery and can support better patient recovery. Hospitals and ambulatory centers are using these materials more often in orthopedics, cardiovascular repair, dental surgery, soft tissue repair, and advanced wound management because they lower long-term procedural burden. The market is still selective rather than universal, but the business case has strengthened as surgeons, payers, and device makers look for lower complication rates and cleaner post-operative pathways.

From 2019 to 2025, the market moved through a period of uneven but persistent growth, expanding from roughly $2.7 billion in 2019 to about $3.8 billion in 2025, despite pressure from pandemic-related procedure delays in 2020 and 2021. Recovery in elective surgery volumes, wider use of absorbable pins, screws, sutures, meshes, and stents, and better clinical acceptance lifted demand through 2022 to 2025. The 2026 base year is estimated at $4.1 billion, and the market is expected to add about $3.1 billion in new annual revenue by 2033 as adoption broadens in both mature and emerging healthcare systems. Growth is not evenly distributed, however, since premium orthopedic and cardiovascular products still account for a disproportionate share of value, while lower-cost wound closure and dental uses drive volume. Stats N Data’s market tracking indicates that pricing discipline and procedural mix will matter as much as unit growth over the forecast period.

The United States remains the largest single market, with 2026 revenue estimated near $1.15 billion and a forecast above $1.95 billion by 2033, supported by high surgical throughput, faster adoption of bioabsorbable orthopedic fixation, and strong outpatient procedure growth. Hospital purchasing is increasingly tied to evidence of fewer reoperations and shorter recovery times, which helps absorbable materials defend premium pricing in spine, trauma, sports medicine, and cardiovascular uses. China is one of the fastest-growing national markets, starting near $460 million in 2026 and moving toward $900 million by 2033 as tertiary hospitals expand advanced surgical capacity and domestic manufacturers scale production. Local procurement pressure remains intense, but rising volumes in trauma care, oral surgery, and minimally invasive procedures are widening the installed base for absorbable devices.

Germany is estimated at about $240 million in 2026 and is expected to approach $380 million by 2033, driven by disciplined adoption in orthopedic and reconstructive surgery and by strong hospital purchasing standards. Japanese demand should rise from roughly $220 million to $350 million over the same period, supported by aging demographics, high procedure quality requirements, and steady use in fracture repair and dental surgery. India, though smaller in value at about $180 million in 2026, has one of the steepest growth curves and could exceed $420 million by 2033 as private hospital chains, medical tourism, and expanding orthopedic access lift volumes. South Korea is projected to increase from around $140 million to $235 million, with demand concentrated in premium hospitals and technologically advanced procedure segments where surgeons are more willing to adopt absorbable fixation and regenerative materials.

Italy and France together represent a meaningful Western European base, with Italy near $130 million in 2026 and France around $175 million, both supported by aging populations, high orthopedic procedure counts, and a steady move toward lower-revision surgical solutions. The United Kingdom is expected to grow from approximately $160 million to $270 million by 2033, helped by surgical backlog reduction efforts and increasing preference for products that reduce follow-up interventions. Canada is smaller but attractive, at about $105 million in 2026 and trending toward $170 million, as public procurement emphasizes clinical durability and total care cost. Mexico and Brazil are more uneven markets, with Mexico near $90 million and Brazil close to $125 million in 2026, but both have room for faster value growth as private hospitals, trauma centers, and dental clinics expand access to higher-specification absorbable products.

Turkey, Indonesia, Vietnam, Saudi Arabia, and the United Arab Emirates collectively show how infrastructure spending is reshaping demand outside the core Western markets. Turkey is likely to move from about $80 million in 2026 to $135 million by 2033, with trauma care and elective surgery remaining the main buyers. Indonesia and Vietnam are lower in current value at roughly $70 million and $55 million, but both are benefiting from hospital modernization and rising surgical capacity, giving them strong percentage growth potential. Saudi Arabia and the United Arab Emirates, at about $95 million and $75 million respectively in 2026, are investing heavily in specialty care and importing premium surgical products, which supports higher pricing and faster uptake of advanced absorbables.

South Africa, Australia, Thailand, Spain, the Netherlands, Poland, Malaysia, and Argentina form a diverse second tier where healthcare structure matters more than simple income level. South Africa is estimated at about $60 million in 2026, with growth tied to private hospital expansion and selective public sector upgrades, while Australia, at roughly $115 million, benefits from strong clinical standards and an established preference for quality surgical products. Thailand and Malaysia, near $65 million and $58 million respectively, are seeing demand rise through medical tourism and private hospital investment, while Spain and the Netherlands, at about $125 million and $95 million, remain stable Western European buyers with solid orthopedic and soft tissue use. Poland and Argentina, at around $85 million and $50 million, are more price-sensitive, but both can post meaningful gains as local procurement improves and surgical volumes rise. Stats N Data sees these markets as important for mid-tier product positioning, where value, clinical acceptance, and distributor reach matter more than brand prestige alone.

By type, absorbable sutures remain the largest volume category, followed by screws and pins, plates and meshes, and newer stent and scaffold formats. Sutures contribute steady baseline demand because they are used across general surgery, dental work, and soft tissue repair, while screws and pins carry higher value in orthopedics and sports injury repair. By application, orthopedics and trauma remain the highest-value segment, but cardiovascular, dental, and wound closure applications are expanding faster in percentage terms as clinical confidence improves. By region, North America leads in value, Europe follows with stable institutional demand, and Asia-Pacific is the fastest-growing region because it combines rising procedure counts with broader hospital buildout and stronger domestic production.

Several drivers are reinforcing the market’s upward path, starting with the medical preference for products that dissolve naturally and remove the need for a second operation. Aging populations are increasing fracture repair, dental restoration, and cardiovascular intervention rates, while younger patients and sports medicine cases are also supporting higher utilization. Healthcare systems are under pressure to reduce readmissions and post-surgical complications, which favors materials that simplify recovery and lower long-term treatment burden. The expansion of ambulatory surgery centers is also meaningful because these facilities favor solutions that shorten follow-up requirements and fit outpatient care protocols.

The main restraints are cost, uneven surgeon familiarity, and variability in degradation behavior across different product classes and patient profiles. In many countries, absorbable materials still carry a premium over conventional metallic or synthetic non-resorbable alternatives, which slows procurement in price-sensitive systems. Clinical performance can also be affected by inflammation risk, load-bearing limits, and differences in how individual patients absorb materials, making some surgeons cautious in complex cases. Regulatory approval timelines and reimbursement gaps remain additional barriers, especially in emerging markets where hospitals may prioritize lower upfront cost over long-term clinical economics.

Opportunity remains strongest in product innovation, local manufacturing, and category expansion into procedures that have historically relied on permanent materials. Dental surgery, soft tissue reconstruction, pediatric orthopedic care, and minimally invasive cardiovascular repair all offer room for greater adoption as products become more predictable and easier to deploy. There is also a commercial opening in mid-price segments, where regional suppliers can compete against global brands with acceptable performance at lower procurement cost. In several markets, especially India, Southeast Asia, and Latin America, the biggest opportunity is not just selling more units but building surgeon education and hospital confidence, which can expand repeat usage over time.

The biggest challenge is proving consistent clinical value across a wide range of applications while managing cost and regulatory complexity. Manufacturers must balance faster resorption with sufficient mechanical strength, and that balance is not the same for every procedure or patient group. Supply chain resilience has become more important since specialty polymers and precision manufacturing steps can expose producers to component shortages and margin pressure. Competitive pressure is also intensifying as more local and regional players enter the field with lower-cost alternatives, making product differentiation harder without strong clinical evidence and service support.

Innovation is moving toward better polymer blends, more predictable degradation profiles, bioactive coatings, and hybrid structures that combine absorbability with higher early-stage strength. Companies are also investing in 3D-printed scaffolds, next-generation sutures, and drug-eluting absorbable platforms that can support healing while reducing infection risk or scar formation. Digital planning and procedure-specific design are helping surgeons choose materials more accurately, especially in orthopedic and reconstructive cases where fit and timing matter. Stats N Data notes that the next competitive edge will likely come from clinical utility plus workflow simplicity, not from material science alone.

Regionally, North America will stay the most profitable market because of reimbursement capacity, advanced clinical adoption, and concentration of high-value procedures. Europe will remain steady but selective, with Germany, France, Italy, the United Kingdom, Spain, and the Netherlands favoring evidence-backed products and tighter procurement scrutiny. Asia-Pacific is the clear growth engine, led by China, India, Japan, South Korea, Indonesia, Vietnam, Thailand, and Malaysia, where procedure volumes, healthcare investment, and domestic production capacity are rising together. The Middle East and Africa and Latin America will contribute smaller shares of total revenue, but their demand is becoming more relevant as private hospitals, trauma care, and specialty surgery centers expand.

The competitive landscape is shaped by a mix of global medtech groups, specialty biomaterial developers, and regional manufacturers that compete on performance, pricing, and regulatory reach. Market leaders tend to win in orthopedic and cardiovascular applications because clinical trust and surgeon familiarity matter more there than in basic wound closure. Smaller companies often enter through dental, soft tissue, or niche absorbable components where approval pathways are shorter and differentiation is easier. Distribution partnerships, hospital contracts, and surgeon training programs remain central to market share defense, and that is likely to intensify as procurement teams demand better evidence of both clinical and financial value.

The analytical approach behind this outlook combines procedure demand logic, device replacement rates, regional healthcare investment patterns, product mix evolution, and adoption barriers by clinical setting. Market sizing is grounded in current installed demand, hospital purchasing behavior, and observed category penetration across the 2019 to 2025 period, then projected forward using realistic assumptions around surgery volumes, pricing, and product mix. Cross-country estimates reflect local healthcare infrastructure, reimbursement strength, and specialty care access rather than simple population size. The resulting view is that the market will continue to grow, but growth will reward companies that can match clinical performance with pricing discipline and local execution.

For suppliers, the most practical strategy is to focus on procedure categories where the value proposition is easiest to prove, especially orthopedics, dental repair, soft tissue closure, and selected cardiovascular uses. Companies should also build stronger evidence packages for payers and hospital buyers, because adoption is still closely tied to total treatment cost rather than product price alone. In faster-growing markets, local manufacturing or assembly can improve access and reduce procurement friction, especially in China, India, Brazil, and Southeast Asia. Product developers that align surgeon education, distributor strength, and regulatory planning will be best placed to convert the market’s clinical promise into durable commercial share.

The Bioresorbable Surgical Material market is experiencing significant growth as a result of increasing demand for innovative and sustainable medical solutions. These materials, which are designed to be absorbed by the body over time, are utilized in a variety of surgical applications, including sutures, wound closure devices, and tissue scaffolds. By eliminating the need for a second surgery to remove devices or implants, bioresorbable options provide a safe, convenient solution that enhances patient recovery and minimizes complications. According to a newly published report by STATS N DATA, the current market size reflects a robust historical performance, with a valuation reaching billions of dollars, driven by heightened demand in both developing and established healthcare markets.

Looking forward, growth projections for the Bioresorbable Surgical Material market remain positive, with expected annual increases influenced by technological advancements and innovations. Key market drivers include the rising prevalence of chronic diseases, an aging population, and a growing emphasis on minimally invasive surgical techniques. Furthermore, increasing funding for research in bioresorbable technologies and collaborations between medical device companies and academic institutions are likely to spur further innovations. However, the market does face challenges such as stringent regulatory environments, which can slow the commercialization of new products, and the potential for high production costs that could limit accessibility in certain regions.

Emerging opportunities in this sector are vast, with ongoing advancements in polymer science and the development of new formulations that enhance the performance of bioresorbable materials. These innovations promise to improve biocompatibility, durability, and controlled degradation rates, which are critical for specific surgical applications. As healthcare providers increasingly lean towards solutions that facilitate patient safety and efficiency, the bioresorbable surgical materials market is poised for transformative growth. Continuous monitoring of market trends and insights from reports like those produced by STATS N DATA will be essential for stakeholders aiming to navigate this evolving landscape and capitalize on the significant potential of bioresorbable technologies.

Understanding the latest trends in the BIORESORBABLE SURGICAL MATERIAL MARKET is crucial for businesses aiming to stay ahead in today's fast-paced environment. Our detailed market research report provides companies and investors with valuable insights into the Global Bioresorbable Surgical Material Industry. This report goes beyond basic data analysis, offering advanced forecasts, revenue estimates, and future trends from 2026 to 2033. It is an essential tool for decision-makers navigating the complexities of this evolving market.

Market Overview and Trends

This report offers a comprehensive look at the current state of the Bioresorbable Surgical Material Market. By analyzing historical data, we uncover key industry insights and track the market's growth over time. This in-depth review provides a clear understanding of the Bioresorbable Surgical Material Market's current status, setting a solid foundation for assessing its future direction. By examining past trends, the report helps predict future growth, allowing stakeholders to adapt and take advantage of new opportunities.

Looking forward, the report includes expert predictions and a thorough analysis of future trends in the Bioresorbable Surgical Material Ecosystem. These growth projections outline the market's expected path, helping stakeholders navigate new opportunities. The report highlights significant growth drivers, such as technological advancements and rising demand in various sectors, while also noting potential challenges like regulatory hurdles and economic uncertainties.

Additionally, the report identifies several growth opportunities, offering strategic insights into both challenges and opportunities within the Bioresorbable Surgical Material Market. Understanding these dynamics equips stakeholders to make better decisions and develop strategies to succeed in a rapidly changing environment.

Market Segmentation

The Bioresorbable Surgical Material Market is divided into several categories, including product type, application/end-user, and geography. The segmentation includes:

Type

• Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Others

Application

• Drug Delivery, Orthopedics, Others

Note: We can customize market segmentation upon request to better meet specific business needs and provide focused insights.

This section dives into the market's segmentation, showing how different components contribute to overall market dynamics. Each segment is assessed based on its size and growth rate, identifying areas of rapid expansion and those with stable growth. This analysis is key to spotting the segments that drive the market and hold strong potential for future development.

The report also includes a Bioresorbable Surgical Material Market attractiveness analysis, evaluating each segment's appeal based on factors like market potential, competitive intensity, and growth prospects. This gives a well-rounded view of which segments are most promising for investment and strategic initiatives, helping businesses allocate resources more effectively and maximize their returns.

Competitive Landscape

Key players featured in this report include:

• Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, Poly-Med, KLS Martin

The Bioresorbable Surgical Material industry is highly competitive, with major players continuously striving to strengthen their positions and expand their reach. The report provides an in-depth look at the competitive landscape, profiling key players in the Bioresorbable Surgical Material Market and detailing their market shares. This section gives a clear picture of the main participants and their roles in the industry.

Additionally, the report includes a SWOT analysis for these major competitors, assessing their strengths, weaknesses, opportunities, and threats. This analysis offers a complete view of the competitive dynamics and strategic positioning of these companies. Knowing the strengths and weaknesses of competitors helps stakeholders identify areas for improvement and craft strategies to gain a competitive edge.

Recent Developments

The report covers recent key developments in the Global Bioresorbable Surgical Material Market, such as mergers, acquisitions, partnerships, and new product launches. These activities have significantly influenced the competitive landscape and shaped trends within the Bioresorbable Surgical Material industry. Staying updated on these developments helps stakeholders anticipate market shifts and adjust their strategies accordingly.

The report also includes a benchmarking analysis of key products and services. By comparing these offerings, the analysis highlights their performance and market positioning. This comparison is crucial for identifying industry best practices and areas that need improvement, providing valuable insights for stakeholders aiming to enhance their products and remain competitive.

Technological Advancements and Innovations

Technological advancements are a major force driving the Global Bioresorbable Surgical Material Market. Our report highlights the latest innovations and technological progress, showing how these developments are reshaping the Bioresorbable Surgical Material industry landscape.

Industry Dynamics and Structure

The report also examines the overall structure and dynamics of the Bioresorbable Surgical Material industry. This analysis provides a clear understanding of how the industry functions and evolves, highlighting the key components and their interactions. Understanding these elements helps stakeholders spot opportunities for collaboration and innovation, which are essential for driving market growth.

Competitive Analysis Using Porter's Five Forces

Our report uses Porter's Five Forces Analysis to assess the competitive landscape of the Bioresorbable Surgical Material Market. This framework looks at the bargaining power of buyers and suppliers, the threat of new entrants and substitute products, and the level of competition among existing players. This analysis helps identify the factors that influence the industry's profitability and competitiveness, providing stakeholders with essential insights for strategic decision-making.

Value Chain Analysis

The report includes a detailed value chain analysis, mapping the journey from suppliers to end-users. This analysis, backed by thorough market studies, provides insights into each phase of the process, highlighting where value is added and identifying potential areas for efficiency improvements. By optimizing the value chain, stakeholders can enhance their operational efficiency and gain a competitive advantage.

Customer Preferences and Trends

The report also highlights key customer preferences and trends, offering insights into what consumers expect from products and services in the Bioresorbable Surgical Material Market. Understanding these preferences helps businesses anticipate market trends and tailor their offerings accordingly, leading to improved customer satisfaction and business growth.

Regulatory Environment

This report thoroughly explores the regulations and standards affecting the Bioresorbable Surgical Material Market, offering a detailed look at the legal framework governing the industry. This information is crucial for understanding the rules and guidelines that market participants must follow. Staying updated on regulatory changes enables stakeholders to maintain compliance and avoid legal issues.

The report also assesses the impact of recent regulatory changes in the Bioresorbable Surgical Material industry and examines how these shifts shape the market. It provides stakeholders with insights to anticipate potential challenges and adapt their strategies accordingly. Understanding the regulatory landscape helps stakeholders make informed decisions and develop strategies that minimize risks while maximizing opportunities.

Furthermore, the report outlines the compliance requirements for participants in the Bioresorbable Surgical Material Market, detailing the steps needed to adhere to regulations and standards. Meeting these compliance demands is vital for maintaining legal and operational integrity within the market. Emphasizing compliance builds trust with customers and strengthens a company's market position.

Market Entry Strategy

Entering the Bioresorbable Surgical Material industry involves several challenges, including high barriers and strong competition. This report identifies the main obstacles that new entrants face when trying to enter the market, such as significant capital requirements, strict regulations, and intense competition from established players.

The report also details critical success factors for new entrants in the Bioresorbable Surgical Material market, focusing on key elements like innovation, effective marketing, strategic partnerships, and a strong value proposition. By addressing these aspects, new entrants can better navigate the market complexities and improve their chances of success.

Additionally, the report provides strategic recommendations for market entry, including practical advice on positioning, customer acquisition, and differentiation tactics. These strategies help new entrants establish a strong market presence and gain a competitive edge, enabling them to overcome entry barriers and capitalize on opportunities in the Bioresorbable Surgical Material Market.

Economic Indicators and Risk Analysis

The report explores how macroeconomic factors, such as GDP growth, inflation, and employment trends, impact the Bioresorbable Surgical Material Market. This analysis provides stakeholders with a comprehensive understanding of the broader economic environment and its influence on the market, supporting informed decision-making.

The report also examines the key risks and uncertainties in the Bioresorbable Surgical Material Market, highlighting potential challenges that could affect market stability and growth. These risks include economic volatility, regulatory changes, and strong market competition. By understanding these risks, stakeholders can develop strategies to mitigate them and enhance market resilience.

The report also offers specific strategies for mitigating identified risks. The impact assessment and mitigation section provides actionable recommendations to help Bioresorbable Surgical Material Market participants manage risks effectively and maintain stability. By addressing these risks proactively, stakeholders can protect their interests and support sustainable growth.

Investment Analysis

This research evaluates the key suppliers and distributors in the Bioresorbable Surgical Material Market, highlighting their capabilities, reliability, and strategic roles within the supply chain. Understanding these dynamics helps stakeholders optimize their operations and strengthen their market positions.

Additionally, the report identifies prime investment opportunities and provides strategic recommendations. It highlights areas with significant potential for high returns, helping investors make informed decisions about where to allocate resources for maximum impact. Strategic investments in these high-potential areas can boost profitability and drive market growth.

The report includes a comprehensive analysis of return on investment (ROI) and financial projections, which are essential for evaluating the expected profitability of investments and crafting informed financial strategies. Understanding these forecasts helps stakeholders assess potential returns and the risks associated with different investment options. By making data-driven investment decisions, stakeholders can maximize their returns and achieve their financial goals.

Furthermore, the report includes feasibility studies for potential new projects or ventures. These studies assess the viability of new initiatives by analyzing market demand, costs, and potential revenue. Such evaluations help investors make informed decisions about pursuing new opportunities. Engaging in feasible projects allows stakeholders to expand their market presence and foster business growth.

Technological and Innovation Insights

The Bioresorbable Surgical Material Market report explores emerging technologies and their potential impact on the market, highlighting how these advancements are setting the stage for the industry's future. This section focuses on innovations that could disrupt the market, creating new opportunities for growth and innovation.

The report also provides a detailed analysis of the innovation landscape and R&D activities within the Bioresorbable Surgical Material Market. It examines ongoing R&D efforts and the state of innovation, offering a clear view of how companies are driving progress and staying competitive. This analysis is crucial for understanding the role of innovation in market growth and identifying strategic investment areas.

Furthermore, the report explores the potential of disruptive technologies in the Bioresorbable Surgical Material Market. These technologies could reshape the industry, creating new opportunities and challenges. By staying informed about these emerging technologies, stakeholders can adjust their strategies and leverage innovation to maintain a competitive advantage.

Geographic Analysis

The report includes a detailed geographic analysis of the Bioresorbable Surgical Material Market, offering insights into regional trends and opportunities. This section covers key regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Understanding these regional dynamics is essential for identifying growth opportunities and tailoring strategies to specific markets.

Regional Insights

The analysis also highlights regional trends and developments, focusing on the main market drivers and challenges in each area. Understanding these regional dynamics helps stakeholders make informed decisions about market entry, expansion, and resource allocation.

Market Size and Growth Rate by Region

The report examines the market size and growth rate across different regions, providing a clear view of which areas are growing the fastest. This information is vital for identifying key markets and planning strategic initiatives.

Emerging Markets and Opportunities

The report identifies emerging markets with high growth potential, offering strategic recommendations for tapping into these opportunities. Understanding these emerging markets is crucial for stakeholders looking to expand their presence and access new growth areas.

Key Questions Addressed in This Report

This comprehensive report answers several key questions, ensuring that stakeholders gain a deep understanding of the Bioresorbable Surgical Material Market:

• What is the size of the Global Bioresorbable Surgical Material Market, and what growth rate is expected during the forecast period?

• What are the main factors driving the growth of the Bioresorbable Surgical Material Market?

• What challenges and risks does the Bioresorbable Surgical Material Market currently face?

• Who are the major players in the Bioresorbable Surgical Material Market?

• What trends are influencing the shares of the Bioresorbable Surgical Material Market?

• What insights can be drawn from applying Porter's Five Forces model to the Bioresorbable Surgical Material Market?

• What global expansion opportunities exist in the Bioresorbable Surgical Material Market?

Why Invest in this Bioresorbable Surgical Material Market Report

• Stay Informed:

  This exclusive research study keeps you updated with the latest information on the competitive landscape, helping you understand the strategies and positions of key players in the market.

• Access Analytical Data and Strategic Planning Methods:

  The report offers comprehensive analytical data and strategic planning tools that enable you to make informed decisions and develop strong market strategies.

• Deepen Understanding of Critical Product Segments:

  This report provides in-depth insights into key product segments, helping you understand their performance, trends, and market potential.

• Explore Market Dynamics Comprehensively:

  This report thoroughly examines the factors influencing market dynamics, providing an analysis of the drivers, challenges, opportunities, and constraints within the market.

• Access Regional Analyses and Business Profiles of Key Stakeholders:

  With detailed regional analyses and profiles of key stakeholders, this report provides insights into regional market conditions and the roles of major market participants.

• Gain Exclusive Insights into Factors Impacting Market Growth:

  Obtain exclusive insights into the factors driving market growth, helping you anticipate changes and adjust your strategies effectively.

Our market research report is an essential resource for investors and businesses seeking a deep understanding of the Global Bioresorbable Surgical Material Market. With comprehensive data, detailed analyses, and actionable insights, this report equips stakeholders with the knowledge they need to make informed decisions, develop successful strategies, and capitalize on the vast opportunities within the Bioresorbable Surgical Material industry. We recommend leveraging these insights to enhance strategic planning and secure a competitive edge in the Bioresorbable Surgical Material Market.